MyJournals Home  
All
Andrology
Astronomy
Biochemistry
Bioinformatics
Biology
Biophysics
Biotechnology
Botany
Cardiology
Cell Biology
Chemistry
Dermatology
Ecology
Epidemiology
Evolutionary Biology
General
Genetics
Genomics
Geology
Geriatrics
Gynaecology
Immunology
Informatics
Mathematics
Medicine
Microbiology
Molecular Biology
Neurology
Nutrition
Oncology
Pathology
Pediatrics
Pharmacology
Philosophy
Physics
Physiology
Psychiatry
Psychology
Statistics
Surgery
Toxicology
Urology
Virology
Zoology

RSS FeedsCombined Next-generation Sequencing and Flow Cytometry Analysis for an Anti-PD-L1 Partial Responder over Time: An Exploration of Mechanisms of PD-L1 Activity and Resistance in Bladder Cancer (European Urology Oncology)

 
 

27 february 2019 07:00:14

 
Combined Next-generation Sequencing and Flow Cytometry Analysis for an Anti-PD-L1 Partial Responder over Time: An Exploration of Mechanisms of PD-L1 Activity and Resistance in Bladder Cancer (European Urology Oncology)
 
As urothelial carcinoma becomes resistant to PD-L1 blockade, additional immune checkpoints may be upregulated, leading to anti-PD-L1 resistance. These data support the concept of combined checkpoint blockade for urothelial carcinoma.


 
87 viewsCategory: Oncology, Urology
 
Long-term Outcomes for Men in a Prostate Screening Trial with an Initial Benign Prostate Biopsy: A Population-based Cohort (European Urology Oncology)
Re: Christopher C. Parker, Nicholas D. James, Christopher D. Brawley, et al. Radiotherapy to the Primary Tumour for Newly Diagnosed, Metastatic Prostate Cancer (STAMPEDE): A Randomised Controlled Phase 3 Trial. Lancet 2018;392:2353-66 (European Urology Oncology)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten